Pilot Study to Evaluate Two Different Non-Invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions (Clinical and Sub-Clinical), When Treated With Aldara 5% (Imiquimod) Cream
Each technique will be assessed by comparison of lesion counts (clinical and sub-clinical)
revealed by the techniques, at start and end of the study and those demonstrated during
treatment. In addition a qualitative assessment of each technique will be made for
performance and ease of use.
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic
To compare the performance of two techniques to monitor the clearance of AK lesions (clinical and subclinical) when treated with Aldara 5% cream by comparison of lesion counts.
8 weeks after the end of treatment
Jean-Paul Ortonne, Professor
CPCAD, Hopital L'Archet 2
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)